$BUDZ
WEED, INC. Stock $budz

$budz Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000109690624001128 Filed on May 15, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue		$0.00
YoY Change
Gross Profit		$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin		$161.8K	$159.9K
YoY Change		1.18%	-67.78%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$5.071K	$20.82K
YoY Change		-75.64%	-40.44%
% of Gross Profit
Operating Expenses	$145.0K	$170.1K	$183.9K
YoY Change	-7.18%	-7.53%	-65.37%
Operating Profit	-$145.0K	-$170.1K	-$183.9K
YoY Change	-7.18%	-7.53%	-65.37%
Interest Expense	$599.00	$599.00	$13.11K
YoY Change	-96.53%	-95.43%	-128.44%
% of Operating Profit
Other Income/Expense, Net	$34.40K	-$599.00
YoY Change
Pretax Income		-$170.7K	-$197.0K
YoY Change		-13.38%	-66.66%
Income Tax	$399.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$111.0K	-$170.7K	-$197.0K
YoY Change	-36.03%	-13.38%	-66.66%
Net Earnings / Revenue
Basic Earnings Per Share			$0.00
Diluted Earnings Per Share		$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	123.5M shares	123.5M shares	123.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$102.7K	$95.75K
YoY Change		7.26%	182.53%
Cash & Equivalents	$15.17K	$102.7K	$95.75K
Short-Term Investments
Other Short-Term Assets	$4.133K	$4.439K	$3.912K
YoY Change	7.55%	13.47%	-78.19%
Inventory
Prepaid Expenses	$17.64K	$21.44K	$19.80K
Receivables		$4.440K	$3.910K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$36.94K	$128.6K	$119.5K
YoY Change	-32.8%	7.63%	126.89%
LONG-TERM ASSETS
Property, Plant & Equipment	$506.3K	$511.3K	$1.198M
YoY Change	-57.02%	-57.32%	-34.97%
Goodwill			$0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$566.4K	$575.2K	$1.277M
YoY Change	-54.81%	-54.96%	-32.15%
TOTAL ASSETS
Total Short-Term Assets	$36.94K	$128.6K	$119.5K
Total Long-Term Assets	$566.4K	$575.2K	$1.277M
Total Assets	$603.3K	$703.8K	$1.397M
YoY Change	-53.89%	-49.61%	-27.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$176.8K	$188.8K	$163.9K
YoY Change	17.01%	15.21%	-29.62%
Accrued Expenses	$77.34K	$71.10K	$45.48K
YoY Change	50.59%	56.33%	-90.29%
Deferred Revenue
YoY Change
Short-Term Debt		$129.3K	$679.9K
YoY Change		-80.98%	-20.37%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$595.8K	$596.3K	$1.396M
YoY Change	-58.77%	-57.27%	-10.31%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$595.8K	$596.3K	$1.396M
Total Long-Term Liabilities		$0.00	$0.00
Total Liabilities	$595.8K	$596.3K	$1.396M
YoY Change	-58.77%	-57.27%	-10.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.67M	-$84.56M	-$84.56M
YoY Change	-0.07%	0.01%
Common Stock	$125.4K	$123.5K	$123.5K
YoY Change	1.58%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.517K	$107.5K	$1.111K
YoY Change
Total Liabilities & Shareholders Equity	$603.3K	$703.8K	$1.397M
YoY Change	-53.89%	-49.61%	-27.82%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$111.0K	-$170.7K	-$197.0K
YoY Change	-36.03%	-13.38%	-66.66%
Depreciation, Depletion And Amortization		$5.071K	$20.82K
YoY Change		-75.64%	-40.44%
Cash From Operating Activities		-$177.7K	-$177.2K
YoY Change		0.31%	-2.56%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$10.00K
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		$0.00	-$10.00K
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-$10.00K	-$32.79K
YoY Change		-69.5%	-116.66%
NET CHANGE
Cash From Operating Activities		-$177.7K	-$177.2K
Cash From Investing Activities		$0.00	-$10.00K
Cash From Financing Activities		-$10.00K	-$32.79K
Net Change In Cash		-$187.7K	-$220.0K
YoY Change		-14.65%
FREE CASH FLOW
Cash From Operating Activities		-$177.7K	-$177.2K
Capital Expenditures		$0.00	$10.00K
Free Cash Flow		-$177.7K	-$187.2K
YoY Change		-5.05%	2.94%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001393772
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123482685	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123482685	shares
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2023Q1	us-gaap	Payments To Acquire Oil And Gas Property PaymentsToAcquireOilAndGasProperty	0	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	333-219922
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	WEED, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0452269
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4920 N. Post Trail
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Tucson
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85750
CY2024Q1	dei	City Area Code CityAreaCode	520
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	818-8582
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	123482685	shares
CY2024Q1	us-gaap	Cash Cash	102696	usd
CY2023Q4	us-gaap	Cash Cash	290409	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	21435	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24622	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	4439	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4855	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	128570	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	319886	usd
CY2024Q1	us-gaap	Land Land	258319	usd
CY2023Q4	us-gaap	Land Land	258319	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	218681	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	218681	usd
CY2024Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	147771	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	147771	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	624771	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	624771	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	113502	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	108431	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	511269	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	516340	usd
CY2024Q1	weed	Finite Lived License FiniteLivedLicense	667	usd
CY2023Q4	weed	Finite Lived License FiniteLivedLicense	667	usd
CY2024Q1	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	50000	usd
CY2023Q4	us-gaap	Finite Lived Trademarks Gross FiniteLivedTrademarksGross	50000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50667	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50667	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-15134	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-14484	usd
CY2024Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	35533	usd
CY2023Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	36183	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28435	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	31653	usd
CY2024Q1	us-gaap	Assets Assets	703807	usd
CY2023Q4	us-gaap	Assets Assets	904062	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	188798	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	183565	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	71100	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	64778	usd
CY2024Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	128879	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	182500	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	13300	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	13000	usd
CY2024Q1	weed	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	125637	usd
CY2023Q4	weed	Notes Payable Related Parties Classified Current1 NotesPayableRelatedPartiesClassifiedCurrent1	133073	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3661	usd
CY2024Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	35800	usd
CY2023Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	35800	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28435	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31653	usd
CY2024Q1	weed	Due To Officers Or Stockholders Current1 DueToOfficersOrStockholdersCurrent1	723	usd
CY2023Q4	weed	Due To Officers Or Stockholders Current1 DueToOfficersOrStockholdersCurrent1	723	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	596333	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	648753	usd
CY2024Q1	us-gaap	Liabilities Liabilities	596333	usd
CY2023Q4	us-gaap	Liabilities Liabilities	648753	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	123482685	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	123482685	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	123483	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	123483	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83818651	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	83818351	usd
CY2024Q1	weed	Subscription Payable SubscriptionPayable	723750	usd
CY2023Q4	weed	Subscription Payable SubscriptionPayable	701250	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84563215	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-84392563	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	4805	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	4788	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	107474	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	255309	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	703807	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	904062	usd
CY2024Q1	us-gaap	Revenues Revenues	0	usd
CY2023Q1	us-gaap	Revenues Revenues	0	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	0	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	0	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	0	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	136565	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	133782	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	25203	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	26096	usd
CY2024Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	8285	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	24030	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	170053	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	183908	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-170053	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-183908	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	599	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	13106	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-599	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13106	usd
CY2024Q1	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-170652	usd
CY2023Q1	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	-197014	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-170652	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-197014	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	17	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-113	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-170635	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-197127	usd
CY2024Q1	weed	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	123809123	shares
CY2023Q1	weed	Basic And Diluted Weighted Average Number Of Shares Outstanding BasicAndDilutedWeightedAverageNumberOfSharesOutstanding	123482685	shares
CY2024Q1	weed	Basic And Diluted Earnings Per Share BasicAndDilutedEarningsPerShare	-0.0014
CY2023Q1	weed	Basic And Diluted Earnings Per Share BasicAndDilutedEarningsPerShare	-0.0016
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	169796	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	90000	usd
CY2023	weed	Imputed Interest On Loan ImputedInterestOnLoan	21494	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-31557	usd
CY2023	weed	Other Comprehensive Income Net OtherComprehensiveIncomeNet	5576	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	255309	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	22500	usd
CY2024Q1	weed	Imputed Interest On Loan ImputedInterestOnLoan	300	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-170652	usd
CY2024Q1	weed	Other Comprehensive Income Net OtherComprehensiveIncomeNet	17	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	107474	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-170652	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-197014	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5721	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	24030	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2564	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2024Q1	weed	Imputed Interest On Loans ImputedInterestOnLoans	300	usd
CY2023Q1	weed	Imputed Interest On Loans ImputedInterestOnLoans	5942	usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	22500	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	22500	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3603	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2540	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5233	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-25900	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-46999	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9271	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-177730	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-177173	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10000	usd
CY2024Q1	weed	Repayments On Notes Payable Related Party RepaymentsOnNotesPayableRelatedParty	10000	usd
CY2023Q1	weed	Repayments On Notes Payable Related Party RepaymentsOnNotesPayableRelatedParty	32789	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-32789	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-187730	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-219962	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-113	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	290409	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	315826	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	102696	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	95751	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	299	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	5113	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">WEED, Inc. (the “Company”), (formerly United Mines, Inc.) was incorporated under the laws of the State of Arizona on August 20, 1999 (“Inception Date”) as Plae, Inc. to engage in the exploration of gold and silver mining properties. On November 26, 2014, the Company was renamed from United Mines, Inc. to WEED, Inc. and was repurposed to pursue a business involving the purchase of land, and building Commercial Grade “Cultivation Centers” to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company’s plan is to become a True “Seed-to-Sale” company providing infrastructure, financial solutions and real estate options in this new emerging market. The Company, under United Mines, was formerly in the process of acquiring mineral properties or claims located in the State of Arizona, USA. The name was previously changed on February 18, 2005 to King Mines, Inc. and then subsequently changed to United Mines, Inc. on March 30, 2005. The Company trades on the OTC Pink Sheets under the stock symbol: BUDZ.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On April 20, 2017, the Company acquired Sangre AT, LLC, a Wyoming company doing business as Sangre AgroTech. (“Sangre”). Sangre is a plant genomic research and breeding company comprised of top-echelon scientists with extensive expertise in genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry, utilizing the most advanced sequencing and analytical technologies and proprietary bioinformatics data systems available. No work is being conducted now until further funds are available.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On May 2, 2022, the Company acquired Hempirical Genetics, LLC, a Arizona company. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company has a calendar year end for reporting purposes.</p>
CY2024Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying consolidated balance sheet at December 31, 2023, has been derived from audited consolidated financial statements and the unaudited condensed consolidated financial statements as of March 31, 2024 and 2023 ( the “financial statements”), have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and should be read in conjunction with the audited consolidated financial statements and related footnotes. It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made which are necessary for a fair financial statements presentation. The consolidated financial statements include all material adjustments (consisting of normal recurring accruals) necessary to make the consolidated financial statements not misleading as required by Regulation S-X, Rule 10-01. Interim result are not necessarily indicative of results for a full year.</p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>

Files In Submission

Name	View Source	Status
0001096906-24-001128-index-headers.html	Edgar Link	pending
0001096906-24-001128-index.html	Edgar Link	pending
0001096906-24-001128.txt	Edgar Link	pending
0001096906-24-001128-xbrl.zip	Edgar Link	pending
budz-10q.htm	Edgar Link	pending
budz-ex311.htm	Edgar Link	pending
budz-ex312.htm	Edgar Link	pending
budz-ex321.htm	Edgar Link	pending
budz-ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
weed-20240331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
weed-20240331_cal.xml	Edgar Link	unprocessable
weed-20240331_lab.xml	Edgar Link	unprocessable
weed-20240331_def.xml	Edgar Link	unprocessable
weed-20240331_pre.xml	Edgar Link	unprocessable
budz-10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BUDZ
WEED, INC. Stock $budz

2024 Q2 Form 10-Q Financial Statement

#000109690624001128 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUDZ WEED, INC. Stock $budz

2024 Q2 Form 10-Q Financial Statement

#000109690624001128 Filed on May 15, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BUDZ
WEED, INC. Stock $budz